Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Cancer. 2015 Dec 22;122(5):758–765. doi: 10.1002/cncr.29824

Table 1.

Clinical characteristics of 167 patients with unresectable intrahepatic cholangiocarcinoma (ICC) and no distant metastases

Characteristic N=167(%)
Demographics
 Median Age (range, yr) 62(30–88)
 Female Gender 99(59)
Presenting Symptom 165
 Abdominal Pain 72(43)
 Jaundice 17(10)
 Elevated LFTs 26(16)
 Non-specific GI symptoms (nausea, weight loss) 17(10)
 Incidentally found during imaging 23(14)
 Non-GI complains (chest pain, back pain, fever) 10(6)
Radiology
 Median Tumor Size (range) 8.5(1.5–16.4)
 Bilobar disease 123(74)
 Multifocal 106(63.5)
Surgical Exploration 117(70)
Unresectability Reason
 Locally advanced/multifocal tumors 104(44)
 Nodal disease 63(27)
Histologic Grade (n) 126
 Well 1(1)
 Moderately 84(67)
 Poor 41(32)
Treatment
 SYS 74(44)
 HAI plus SYS 93(56)
Surgery with curative intent after treatment 9(5)

HAI: Hepatic Arterial Infusion, SYS: systemic chemotherapy